Amgen

Amgen is a leading global biotechnology company dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Established in 1980, Amgen has been at the forefront of biotechnology, leveraging human genetic data and advanced technologies to address serious illnesses.

Therapeutic Areas and Products

Amgen's extensive portfolio spans several therapeutic areas, including oncology, cardiovascular diseases, bone health, and inflammation. Notable products include:

• Enbrel (etanercept): Used to treat various forms of arthritis.
• Prolia (denosumab): Indicated for postmenopausal osteoporosis.
• Repatha (evolocumab): Aimed at lowering cholesterol levels.
• Kyprolis (carfilzomib): Utilized in cancer treatment.
• Otezla (apremilast): Prescribed for psoriasis and psoriatic arthritis.

These therapies have significantly impacted patient care, offering new hope for those with serious health conditions.

Research and Development

Amgen invests heavily in research and development, employing advanced tools like artificial intelligence and human data to drive innovation. The company's robust pipeline includes treatments for cancer, heart disease, osteoporosis, inflammatory diseases, and rare conditions.

This commitment underscores Amgen's dedication to advancing science and improving patient outcomes.

Global Presence and Operations

Headquartered in Thousand Oaks, California, Amgen operates in approximately 100 countries. The company has a significant presence in the United States, with facilities in multiple locations:

• Thousand Oaks, CA: Corporate headquarters.
• Glendale, CA: Research and development center.
• Columbus, OH: Biotech manufacturing plant.
• Cleveland, OH: Biotech manufacturing plant.
• Winston-Salem, NC: Biotech manufacturing plant.

Internationally, Amgen has manufacturing operations in Ireland, the Netherlands, and Singapore. The company is also expanding its footprint in India, with a $200 million investment in a new technology center in Hyderabad, focusing on AI and data science for drug development.

Commitment to Patients and Innovation

Amgen's mission is to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.

The company's dedication to innovation, patient care, and global expansion reflects its ongoing commitment to improving health outcomes worldwide.